顱內動脈瘤市場規模、佔有率和成長分析（按產品類型、最終用戶和地區）- 產業預測，2025-2032 年

Intracranial Aneurysm Market Size, Share, Growth Analysis, By Product Type (Aneurysm Therapeutic Devices, Embolization Devices), By Type (Saccular aneurysm, Fusiform aneurysm), By End-User, By Region - Industry Forecast 2025-2032

出版日期: 2025年01月14日 | 出版商:

SkyQuest | 英文 236 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2023 年全球顱內動脈瘤市場規模價值為 13 億美元，預計將從 2024 年的 14.2 億美元成長到 2032 年的 28.2 億美元，預測期內（2025-2032 年）的複合年成長率為 9.0%。

受人口老化、早期診斷和早期療育意識的增強以及醫療技術的強勁進步的推動，全球顱內動脈瘤市場預計將持續成長。已開發市場和新興市場的醫療保健支出不斷增加，擴大了獲得基本服務的機會，特別是在顱內動脈瘤的診斷和治療方面。盤管固定和血流改道等微創血管內治療方法的興起因其風險較低、住院時間較短、恢復時間縮短而受到關注。此外，影像技術的改進使得檢測和治療計劃更加準確。然而，治療費用高、血管內治療複雜等挑戰可能會阻礙市場擴張。隨著意識和技術的不斷進步，解決這些障礙對於最大限度地發揮市場潛力至關重要。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲國家
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前 5 家公司對比
主要企業市場定位（2024年）
主要市場參與者所採用的策略
近期市場趨勢
公司市場佔有率分析（2024 年）
主要企業簡介
- 公司簡介
- 產品系列分析
- 按細分市場分析市場佔有率
- 收益與前一年同期比較（2022-2024 年）

主要企業簡介

Medtronic plc（Ireland）
Stryker Corporation（United States）
MicroPort Scientific Corporation（China）
Johnson & Johnson Services, Inc.（United States）
MicroVention Inc.（United States）
B. Braun Melsungen AG（Germany）
Integra LifeSciences（United States）
RAUMEDIC AG（Germany）
Terumo Corporation（Japan）
Delta Surgical（United Kingdom）
MicroVention Terumo（United States）
Penumbra, Inc.（United States）
Balt USA（United States）
Phenox GmbH（Germany）
InspireMD, Inc.（Israel）
Kaneka Medix Corporation（Japan）
Evasc Neurovascular Enterprises ULC（Canada）

結論和建議

簡介目錄

Product Code: SQMIG35A2427

Global Intracranial Aneurysm Market size was valued at USD 1.3 billion in 2023 and is poised to grow from USD 1.42 billion in 2024 to USD 2.82 billion by 2032, growing at a CAGR of 9.0% during the forecast period (2025-2032).

The global intracranial aneurysm market is poised for sustained growth, fueled by an aging population, heightened awareness around early diagnosis and intervention, and robust advancements in medical technology. Increased healthcare spending in both developed and emerging markets has broadened access to essential services, particularly in diagnosing and treating intracranial aneurysms. The rise of minimally invasive endovascular techniques, like coiling and flow diversion, has garnered attention due to their lower risk profiles, reduced hospital stays, and improved recovery times. Additionally, enhanced imaging technologies have enabled more accurate detection and treatment planning. However, challenges such as high treatment costs and the complexities of endovascular procedures may hinder market expansion. As awareness and technology continue to advance, addressing these barriers will be crucial for maximizing market potential.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Intracranial Aneurysm market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Intracranial Aneurysm Market Segmental Analysis

Global Intracranial Aneurysm Market is segmented by Product Type, Type, End-User and region. Based on Product Type, the market is segmented into Aneurysm Therapeutic Devices, Embolization Devices, Aspiration Devices and Access Devices. Based on Type, the market is segmented into Saccular aneurysm, Fusiform aneurysm and Mycotic aneurysm. Based on End-User, the market is segmented into Hospitals, Specialty Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Intracranial Aneurysm Market

The global market for intracranial aneurysms is primarily driven by significant technological advancements in the medical field. Innovations such as minimally invasive endovascular procedures, enhanced imaging techniques, and the introduction of cutting-edge devices are pivotal in fostering market expansion. These developments not only improve treatment efficacy but also contribute to enhanced patient experiences by minimizing discomfort and expediting recovery periods. As healthcare professionals adopt these advanced technologies, the overall quality of care for patients with intracranial aneurysms is expected to improve, further propelling growth in this market segment.

Restraints in the Global Intracranial Aneurysm Market

The global market for intracranial aneurysms faces significant constraints due to exorbitant treatment costs. Patients requiring intervention for these conditions often encounter substantial expenses, particularly in cases that involve complex procedures or advanced medical devices. This financial burden can create barriers to accessing necessary care for some individuals and potentially lead to disparities in treatment options. Additionally, the high costs can place considerable strain on healthcare systems, affecting their ability to provide comprehensive care for all patients suffering from intracranial aneurysms. Ultimately, these economic factors can hinder overall market growth and patient outcomes in this critical area of healthcare.

Market Trends of the Global Intracranial Aneurysm Market

The Global Intracranial Aneurysm market is witnessing a significant shift towards minimally invasive procedures, driven by advancements in endovascular techniques such as coiling and flow diversion. These methods are increasingly favored for their lower invasiveness, shorter recovery times, and improved patient outcomes compared to traditional open surgical interventions. As healthcare providers and patients prioritize safety and efficiency, the demand for these innovative treatments continues to surge, leading to enhanced market growth. This trend not only reflects broader healthcare advancements but also underscores the imperative for ongoing research and development in neurovascular therapies, positioning the market for sustained expansion in the coming years.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies
Technological Advancement

Global Intracranial Aneurysm Market Size by Product Type & CAGR (2025-2032)

Market Overview
Aneurysm Therapeutic Devices
- Clips
- Coils
- Intravascular Devices
- Flow Diverter
Embolization Devices
- Occlusion Catheters
- Embolic Agent
Aspiration Devices
- Aspiration Catheter
- Clot Retrieval Device
Access Devices
- Micro Catheter
- Guidewire

Global Intracranial Aneurysm Market Size by Type & CAGR (2025-2032)

Market Overview
Saccular aneurysm
Fusiform aneurysm
Mycotic aneurysm

Global Intracranial Aneurysm Market Size by End-User & CAGR (2025-2032)

Market Overview
Hospitals
Specialty Clinics
Others

Global Intracranial Aneurysm Market Size & CAGR (2025-2032)

North America (Product Type, Type, End-User)
- US
- Canada
Europe (Product Type, Type, End-User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product Type, Type, End-User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product Type, Type, End-User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product Type, Type, End-User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MicroPort Scientific Corporation (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson Services, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MicroVention Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Integra LifeSciences (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
RAUMEDIC AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Delta Surgical (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MicroVention Terumo (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Penumbra, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Balt USA (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Phenox GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
InspireMD, Inc. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kaneka Medix Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Evasc Neurovascular Enterprises ULC (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments